Chitotriosidase and Neopterin as Potential Biomarkers for the Evaluation of Complicated Cholecystitis—A Pilot Study

Gallstones are a common surgical pathology. Laparoscopic cholecystectomy represents the elective treatment. Complicated cases can increase the rate of conversion, the duration, and the difficulty of the intervention, along with the hospitalization period. A prospective cohort study was conducted on...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical medicine Vol. 12; no. 4; p. 1641
Main Authors Nechita, Vlad-Ionuţ, Hajjar, Nadim Al, Drugan, Cristina, Cătană, Cristina-Sorina, Moiş, Emil, Nechita, Mihaela-Ancuţa, Graur, Florin
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 18.02.2023
MDPI
Subjects
Online AccessGet full text
ISSN2077-0383
2077-0383
DOI10.3390/jcm12041641

Cover

Abstract Gallstones are a common surgical pathology. Laparoscopic cholecystectomy represents the elective treatment. Complicated cases can increase the rate of conversion, the duration, and the difficulty of the intervention, along with the hospitalization period. A prospective cohort study was conducted on 51 patients with gallstones. Only subjects with normal renal, pancreatic, and hepatic functions were included. The severity of cholecystitis was evaluated by considering the ultrasound examination, intraoperative findings, and pathology report. We evaluated two potential biomarkers, namely neopterin and chitotriosidase, by comparing their levels before and after the intervention for chronic (n = 36) and complicated (n = 15) cases, as well as their eventual association with the hospitalization period. Subjects with complicated cholecystitis had significantly higher (p = 0.01) neopterin levels at presentation (16.82 nmol/L vs. 11.92 nmol/L, median values), but the differences in chitotriosidase activity between complicated (170.00 nmol/mL/h) and chronic (160.00 nmol/mL/h) cases were not significant (p = 0.66). Patients with neopterin levels above the cut-off value 14.69 nmol/L had a 3.34 times higher risk of complicated cholecystitis. Twenty-four hours after the laparoscopic cholecystectomy, the differences in neopterin level and chitotriosidase activity between chronic and complicated cases were not significant. A significant decrease in chitotriosidase activity was observed after the intervention, only for complicated cases (190 nmol/mL/h vs. 145 nmol/mL/h, p = 0.007); for neopterin, the postoperative decrease was not statistically significant (19.42 nmol/L vs. 10.92 nmol/L, p = 0.06). No significant association with the hospitalization period was observed. Neopterin may be a useful biomarker for complicated cholecystitis, and chitotriosidase may have prognostic utility in early patient follow-up.
AbstractList Gallstones are a common surgical pathology. Laparoscopic cholecystectomy represents the elective treatment. Complicated cases can increase the rate of conversion, the duration, and the difficulty of the intervention, along with the hospitalization period. A prospective cohort study was conducted on 51 patients with gallstones. Only subjects with normal renal, pancreatic, and hepatic functions were included. The severity of cholecystitis was evaluated by considering the ultrasound examination, intraoperative findings, and pathology report. We evaluated two potential biomarkers, namely neopterin and chitotriosidase, by comparing their levels before and after the intervention for chronic (n = 36) and complicated (n = 15) cases, as well as their eventual association with the hospitalization period. Subjects with complicated cholecystitis had significantly higher (p = 0.01) neopterin levels at presentation (16.82 nmol/L vs. 11.92 nmol/L, median values), but the differences in chitotriosidase activity between complicated (170.00 nmol/mL/h) and chronic (160.00 nmol/mL/h) cases were not significant (p = 0.66). Patients with neopterin levels above the cut-off value 14.69 nmol/L had a 3.34 times higher risk of complicated cholecystitis. Twenty-four hours after the laparoscopic cholecystectomy, the differences in neopterin level and chitotriosidase activity between chronic and complicated cases were not significant. A significant decrease in chitotriosidase activity was observed after the intervention, only for complicated cases (190 nmol/mL/h vs. 145 nmol/mL/h, p = 0.007); for neopterin, the postoperative decrease was not statistically significant (19.42 nmol/L vs. 10.92 nmol/L, p = 0.06). No significant association with the hospitalization period was observed. Neopterin may be a useful biomarker for complicated cholecystitis, and chitotriosidase may have prognostic utility in early patient follow-up.
Gallstones are a common surgical pathology. Laparoscopic cholecystectomy represents the elective treatment. Complicated cases can increase the rate of conversion, the duration, and the difficulty of the intervention, along with the hospitalization period. A prospective cohort study was conducted on 51 patients with gallstones. Only subjects with normal renal, pancreatic, and hepatic functions were included. The severity of cholecystitis was evaluated by considering the ultrasound examination, intraoperative findings, and pathology report. We evaluated two potential biomarkers, namely neopterin and chitotriosidase, by comparing their levels before and after the intervention for chronic ( n = 36) and complicated ( n = 15) cases, as well as their eventual association with the hospitalization period. Subjects with complicated cholecystitis had significantly higher ( p = 0.01) neopterin levels at presentation (16.82 nmol/L vs. 11.92 nmol/L, median values), but the differences in chitotriosidase activity between complicated (170.00 nmol/mL/h) and chronic (160.00 nmol/mL/h) cases were not significant ( p = 0.66). Patients with neopterin levels above the cut-off value 14.69 nmol/L had a 3.34 times higher risk of complicated cholecystitis. Twenty-four hours after the laparoscopic cholecystectomy, the differences in neopterin level and chitotriosidase activity between chronic and complicated cases were not significant. A significant decrease in chitotriosidase activity was observed after the intervention, only for complicated cases (190 nmol/mL/h vs. 145 nmol/mL/h, p = 0.007); for neopterin, the postoperative decrease was not statistically significant (19.42 nmol/L vs. 10.92 nmol/L, p = 0.06). No significant association with the hospitalization period was observed. Neopterin may be a useful biomarker for complicated cholecystitis, and chitotriosidase may have prognostic utility in early patient follow-up.
Gallstones are a common surgical pathology. Laparoscopic cholecystectomy represents the elective treatment. Complicated cases can increase the rate of conversion, the duration, and the difficulty of the intervention, along with the hospitalization period. A prospective cohort study was conducted on 51 patients with gallstones. Only subjects with normal renal, pancreatic, and hepatic functions were included. The severity of cholecystitis was evaluated by considering the ultrasound examination, intraoperative findings, and pathology report. We evaluated two potential biomarkers, namely neopterin and chitotriosidase, by comparing their levels before and after the intervention for chronic ( = 36) and complicated ( = 15) cases, as well as their eventual association with the hospitalization period. Subjects with complicated cholecystitis had significantly higher ( = 0.01) neopterin levels at presentation (16.82 nmol/L vs. 11.92 nmol/L, median values), but the differences in chitotriosidase activity between complicated (170.00 nmol/mL/h) and chronic (160.00 nmol/mL/h) cases were not significant ( = 0.66). Patients with neopterin levels above the cut-off value 14.69 nmol/L had a 3.34 times higher risk of complicated cholecystitis. Twenty-four hours after the laparoscopic cholecystectomy, the differences in neopterin level and chitotriosidase activity between chronic and complicated cases were not significant. A significant decrease in chitotriosidase activity was observed after the intervention, only for complicated cases (190 nmol/mL/h vs. 145 nmol/mL/h, = 0.007); for neopterin, the postoperative decrease was not statistically significant (19.42 nmol/L vs. 10.92 nmol/L, = 0.06). No significant association with the hospitalization period was observed. Neopterin may be a useful biomarker for complicated cholecystitis, and chitotriosidase may have prognostic utility in early patient follow-up.
Gallstones are a common surgical pathology. Laparoscopic cholecystectomy represents the elective treatment. Complicated cases can increase the rate of conversion, the duration, and the difficulty of the intervention, along with the hospitalization period. A prospective cohort study was conducted on 51 patients with gallstones. Only subjects with normal renal, pancreatic, and hepatic functions were included. The severity of cholecystitis was evaluated by considering the ultrasound examination, intraoperative findings, and pathology report. We evaluated two potential biomarkers, namely neopterin and chitotriosidase, by comparing their levels before and after the intervention for chronic (n = 36) and complicated (n = 15) cases, as well as their eventual association with the hospitalization period. Subjects with complicated cholecystitis had significantly higher (p = 0.01) neopterin levels at presentation (16.82 nmol/L vs. 11.92 nmol/L, median values), but the differences in chitotriosidase activity between complicated (170.00 nmol/mL/h) and chronic (160.00 nmol/mL/h) cases were not significant (p = 0.66). Patients with neopterin levels above the cut-off value 14.69 nmol/L had a 3.34 times higher risk of complicated cholecystitis. Twenty-four hours after the laparoscopic cholecystectomy, the differences in neopterin level and chitotriosidase activity between chronic and complicated cases were not significant. A significant decrease in chitotriosidase activity was observed after the intervention, only for complicated cases (190 nmol/mL/h vs. 145 nmol/mL/h, p = 0.007); for neopterin, the postoperative decrease was not statistically significant (19.42 nmol/L vs. 10.92 nmol/L, p = 0.06). No significant association with the hospitalization period was observed. Neopterin may be a useful biomarker for complicated cholecystitis, and chitotriosidase may have prognostic utility in early patient follow-up.Gallstones are a common surgical pathology. Laparoscopic cholecystectomy represents the elective treatment. Complicated cases can increase the rate of conversion, the duration, and the difficulty of the intervention, along with the hospitalization period. A prospective cohort study was conducted on 51 patients with gallstones. Only subjects with normal renal, pancreatic, and hepatic functions were included. The severity of cholecystitis was evaluated by considering the ultrasound examination, intraoperative findings, and pathology report. We evaluated two potential biomarkers, namely neopterin and chitotriosidase, by comparing their levels before and after the intervention for chronic (n = 36) and complicated (n = 15) cases, as well as their eventual association with the hospitalization period. Subjects with complicated cholecystitis had significantly higher (p = 0.01) neopterin levels at presentation (16.82 nmol/L vs. 11.92 nmol/L, median values), but the differences in chitotriosidase activity between complicated (170.00 nmol/mL/h) and chronic (160.00 nmol/mL/h) cases were not significant (p = 0.66). Patients with neopterin levels above the cut-off value 14.69 nmol/L had a 3.34 times higher risk of complicated cholecystitis. Twenty-four hours after the laparoscopic cholecystectomy, the differences in neopterin level and chitotriosidase activity between chronic and complicated cases were not significant. A significant decrease in chitotriosidase activity was observed after the intervention, only for complicated cases (190 nmol/mL/h vs. 145 nmol/mL/h, p = 0.007); for neopterin, the postoperative decrease was not statistically significant (19.42 nmol/L vs. 10.92 nmol/L, p = 0.06). No significant association with the hospitalization period was observed. Neopterin may be a useful biomarker for complicated cholecystitis, and chitotriosidase may have prognostic utility in early patient follow-up.
Audience Academic
Author Drugan, Cristina
Moiş, Emil
Cătană, Cristina-Sorina
Nechita, Vlad-Ionuţ
Nechita, Mihaela-Ancuţa
Graur, Florin
Hajjar, Nadim Al
AuthorAffiliation 5 Ion Chiricuță Oncology Institute, Republicii Str. No. 34–36, 400015 Cluj-Napoca, Romania
1 Department of Medical Informatics and Biostatistics, Iuliu Hațieganu University of Medicine and Pharmacy, Louis Pasteur Str. No. 6, 400349 Cluj-Napoca, Romania
3 Department of Surgery, Iuliu Hațieganu University of Medicine and Pharmacy, Croitorilor Str. No. 19–21, 400162 Cluj-Napoca, Romania
2 Octavian Fodor Regional Institute of Gastroenterology and Hepatology, 400162 Cluj-Napoca, Romania
4 Department of Medical Biochemistry, Iuliu Haţieganu University of Medicine and Pharmacy, Louis Pasteur Str. No. 6, 400349 Cluj-Napoca, Romania
AuthorAffiliation_xml – name: 2 Octavian Fodor Regional Institute of Gastroenterology and Hepatology, 400162 Cluj-Napoca, Romania
– name: 4 Department of Medical Biochemistry, Iuliu Haţieganu University of Medicine and Pharmacy, Louis Pasteur Str. No. 6, 400349 Cluj-Napoca, Romania
– name: 3 Department of Surgery, Iuliu Hațieganu University of Medicine and Pharmacy, Croitorilor Str. No. 19–21, 400162 Cluj-Napoca, Romania
– name: 1 Department of Medical Informatics and Biostatistics, Iuliu Hațieganu University of Medicine and Pharmacy, Louis Pasteur Str. No. 6, 400349 Cluj-Napoca, Romania
– name: 5 Ion Chiricuță Oncology Institute, Republicii Str. No. 34–36, 400015 Cluj-Napoca, Romania
Author_xml – sequence: 1
  givenname: Vlad-Ionuţ
  surname: Nechita
  fullname: Nechita, Vlad-Ionuţ
– sequence: 2
  givenname: Nadim Al
  surname: Hajjar
  fullname: Hajjar, Nadim Al
– sequence: 3
  givenname: Cristina
  orcidid: 0000-0001-9136-2530
  surname: Drugan
  fullname: Drugan, Cristina
– sequence: 4
  givenname: Cristina-Sorina
  surname: Cătană
  fullname: Cătană, Cristina-Sorina
– sequence: 5
  givenname: Emil
  surname: Moiş
  fullname: Moiş, Emil
– sequence: 6
  givenname: Mihaela-Ancuţa
  surname: Nechita
  fullname: Nechita, Mihaela-Ancuţa
– sequence: 7
  givenname: Florin
  orcidid: 0000-0002-5887-3408
  surname: Graur
  fullname: Graur, Florin
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36836175$$D View this record in MEDLINE/PubMed
BookMark eNptkk1rFDEYxwep2Fp78i4BL4JszdtMJhdhHeoLFC2o55DJPOlmzUy2SaawNz-En9BPYmpb3ZYmh4Tk9_zgnzxPq70pTFBVzwk-ZkziN2szEoo5aTh5VB1QLMQCs5bt7ez3q6OU1riMtuWUiCfVPmta1hBRH1Rzt3I55OhCcoNOgPQ0oM8QNhmim5BO6CxkmLLTHr1zYdTxB8SEbIgorwCdXGo_6-zChIJFXRg33hmdYUDdKngw25Rddun3z19LdOZ8yOhrnofts-qx1T7B0c16WH1_f_Kt-7g4_fLhU7c8XRgumrywhltBGeW64YxA29C-t0BryqTpSU-Y5MDqgWvbatpY3EKPqQRt64HqltXssHp77d3M_QiDKUGi9moTXQmyVUE7dfdmcit1Hi6VlA2XEhfBqxtBDBczpKxGlwx4rycIc1JUtBg3VIq2oC_voeswx6nEK5SQRdfU_D91rj0oN9ny9tpcSdVS1JgxLmtSqOMHqDIHGJ0pHWBdOb9T8GI36L-Etx9dAHINmBhSimCVcfnvxxWz84pgddVPaqefSs3rezW32ofoP4DAzGQ
CitedBy_id crossref_primary_10_3390_biomedicines11051294
crossref_primary_10_3390_jcm12216946
crossref_primary_10_4274_imj_galenos_2024_94467
Cites_doi 10.5009/gnl.2012.6.2.172
10.1007/s10620-006-9107-3
10.1093/clinchem/33.1.62
10.2174/1389200024605082
10.1155/2016/2682680
10.4103/0019-5278.44690
10.5505/tjtes.2012.00087
10.3390/antiox7070080
10.1016/S0002-9610(05)80930-4
10.3390/diagnostics11020263
10.1186/s13017-015-0005-x
10.1074/jbc.270.5.2198
10.1016/j.ajem.2011.04.006
10.1093/intimm/dxh328
10.3889/oamjms.2021.5465
10.3390/ijms22136966
10.1172/JCI117084
10.1002/jcla.20063
10.1046/j.1440-1622.2000.01851.x
10.1007/s00534-006-1159-4
10.1007/978-981-13-7318-3_11
10.1007/s00011-003-1181-9
10.9738/INTSURG-D-13-00222.1
10.1148/radiographics.20.3.g00ma16751
ContentType Journal Article
Copyright COPYRIGHT 2023 MDPI AG
2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2023 by the authors. 2023
Copyright_xml – notice: COPYRIGHT 2023 MDPI AG
– notice: 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2023 by the authors. 2023
DBID AAYXX
CITATION
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.3390/jcm12041641
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
ProQuest One
ProQuest Central Korea
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef

PubMed
Publicly Available Content Database
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X7
  name: Health & Medical Collection (ProQuest)
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2077-0383
ExternalDocumentID PMC9964990
A750334951
36836175
10_3390_jcm12041641
Genre Journal Article
GeographicLocations Romania
GeographicLocations_xml – name: Romania
GrantInformation_xml – fundername: Iuliu Hațieganu University of Medicine and Pharmacy
  grantid: PCD 1529/50/18.01.2019
– fundername: “Iuliu Hațieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania, Doctoral Research Program
  grantid: PCD 1529/50
GroupedDBID 53G
5VS
7X7
8FI
8FJ
AADQD
AAFWJ
AAYXX
ABDBF
ABUWG
ACUHS
ADBBV
AFKRA
AFZYC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BENPR
CCPQU
CITATION
DIK
FYUFA
HMCUK
HYE
IAO
IHR
ITC
KQ8
M48
MODMG
M~E
OK1
PGMZT
PHGZM
PHGZT
PIMPY
RPM
UKHRP
GROUPED_DOAJ
NPM
PMFND
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c476t-fc4f72324a6431e862bbfe25239cb1b1394e35d4af8a26f08eb029eaf5d2a8353
IEDL.DBID M48
ISSN 2077-0383
IngestDate Thu Aug 21 18:37:43 EDT 2025
Fri Sep 05 03:23:12 EDT 2025
Sun Jun 29 16:10:08 EDT 2025
Tue Jun 17 22:20:25 EDT 2025
Tue Jun 10 21:12:53 EDT 2025
Thu Jan 02 22:53:00 EST 2025
Thu Apr 24 23:05:43 EDT 2025
Tue Jul 01 02:09:45 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords complicated cholecystitis
chitotriosidase
neopterin
laparoscopic cholecystectomy
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c476t-fc4f72324a6431e862bbfe25239cb1b1394e35d4af8a26f08eb029eaf5d2a8353
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-5887-3408
0000-0001-9136-2530
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/jcm12041641
PMID 36836175
PQID 2779499654
PQPubID 5046890
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9964990
proquest_miscellaneous_2780062978
proquest_journals_2779499654
gale_infotracmisc_A750334951
gale_infotracacademiconefile_A750334951
pubmed_primary_36836175
crossref_citationtrail_10_3390_jcm12041641
crossref_primary_10_3390_jcm12041641
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20230218
PublicationDateYYYYMMDD 2023-02-18
PublicationDate_xml – month: 2
  year: 2023
  text: 20230218
  day: 18
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Journal of clinical medicine
PublicationTitleAlternate J Clin Med
PublicationYear 2023
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Kumar (ref_10) 2019; 1142
Kamal (ref_24) 2021; 9
Dal (ref_25) 2018; 25
Sakorafas (ref_3) 2007; 52
Hoffmann (ref_19) 2003; 52
Pingle (ref_16) 2008; 12
Hirota (ref_26) 2007; 14
Renkema (ref_11) 2005; 17
Elmonem (ref_13) 2016; 2016
ref_17
Werner (ref_21) 1987; 33
ref_15
Acar (ref_22) 2012; 30
Bortoff (ref_4) 2000; 20
Malaguarnera (ref_12) 2005; 19
Sugrue (ref_29) 2015; 10
Prakash (ref_28) 2022; 14
Kapan (ref_7) 2015; 100
Renkema (ref_14) 1995; 270
ref_20
Mentes (ref_23) 2012; 18
Stinton (ref_2) 2012; 6
Murr (ref_18) 2002; 3
ref_1
Hunt (ref_8) 2000; 70
Hollak (ref_27) 1994; 93
ref_9
ref_5
ref_6
References_xml – volume: 6
  start-page: 172
  year: 2012
  ident: ref_2
  article-title: Epidemiology of Gallbladder Disease: Cholelithiasis and Cancer
  publication-title: Gut Liver
  doi: 10.5009/gnl.2012.6.2.172
– volume: 52
  start-page: 1313
  year: 2007
  ident: ref_3
  article-title: Asymptomatic Cholelithiasis: Is Cholecystectomy Really Needed? A Critical Reappraisal 15 Years after the Introduction of Laparoscopic Cholecystectomy
  publication-title: Dig. Dis. Sci.
  doi: 10.1007/s10620-006-9107-3
– ident: ref_5
– volume: 33
  start-page: 62
  year: 1987
  ident: ref_21
  article-title: Determination of Neopterin in Serum and Urine
  publication-title: Clin. Chem.
  doi: 10.1093/clinchem/33.1.62
– volume: 3
  start-page: 175
  year: 2002
  ident: ref_18
  article-title: Neopterin as a Marker for Immune System Activation
  publication-title: Curr. Drug Metab.
  doi: 10.2174/1389200024605082
– volume: 2016
  start-page: e2682680
  year: 2016
  ident: ref_13
  article-title: Immunomodulatory Effects of Chitotriosidase Enzyme
  publication-title: Enzym. Res.
  doi: 10.1155/2016/2682680
– volume: 12
  start-page: 107
  year: 2008
  ident: ref_16
  article-title: Neopterin: Biomarker of Cell-Mediated Immunity and Potent Usage as Biomarker in Silicosis and Other Occupational Diseases
  publication-title: Indian J. Occup. Environ. Med.
  doi: 10.4103/0019-5278.44690
– volume: 18
  start-page: 1
  year: 2012
  ident: ref_23
  article-title: Is Neopterin a Diagnostic Marker of Acute Appendicitis?
  publication-title: Ulus. Travma Ve Acil Cerrahi Derg.
  doi: 10.5505/tjtes.2012.00087
– ident: ref_20
  doi: 10.3390/antiox7070080
– ident: ref_6
  doi: 10.1016/S0002-9610(05)80930-4
– ident: ref_9
  doi: 10.3390/diagnostics11020263
– ident: ref_1
– volume: 10
  start-page: 14
  year: 2015
  ident: ref_29
  article-title: Grading Operative Findings at Laparoscopic Cholecystectomy—A New Scoring System
  publication-title: World J. Emerg. Surg.
  doi: 10.1186/s13017-015-0005-x
– volume: 270
  start-page: 2198
  year: 1995
  ident: ref_14
  article-title: Purification and Characterization of Human Chitotriosidase, a Novel Member of the Chitinase Family of Proteins
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.270.5.2198
– volume: 30
  start-page: 775
  year: 2012
  ident: ref_22
  article-title: Serum Chitotriosidase Activity in Acute Appendicitis: Preliminary Results
  publication-title: Am. J. Emerg. Med.
  doi: 10.1016/j.ajem.2011.04.006
– volume: 17
  start-page: 1505
  year: 2005
  ident: ref_11
  article-title: Characterization of Human Phagocyte-Derived Chitotriosidase, a Component of Innate Immunity
  publication-title: Int. Immunol.
  doi: 10.1093/intimm/dxh328
– volume: 9
  start-page: 42
  year: 2021
  ident: ref_24
  article-title: Comparative Study between Neopterin and Alvarado Score in the Diagnosis of Acute Appendicitis and Its Severity
  publication-title: Open Access Maced. J. Med. Sci.
  doi: 10.3889/oamjms.2021.5465
– volume: 25
  start-page: 229
  year: 2018
  ident: ref_25
  article-title: Role of Alvarado Score and Biological Indicators of C-Reaktif Protein, Procalicitonin and Neopterin in Diagnosis of Acute Appendicitis
  publication-title: Ulus. Travma Ve Acil Cerrahi Derg.
– ident: ref_15
  doi: 10.3390/ijms22136966
– volume: 93
  start-page: 1288
  year: 1994
  ident: ref_27
  article-title: Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI117084
– volume: 19
  start-page: 128
  year: 2005
  ident: ref_12
  article-title: Interferon-Gamma, Tumor Necrosis Factor-Alpha, and Lipopolysaccharide Promote Chitotriosidase Gene Expression in Human Macrophages
  publication-title: J. Clin. Lab. Anal.
  doi: 10.1002/jcla.20063
– volume: 70
  start-page: 428
  year: 2000
  ident: ref_8
  article-title: Gangrenous Cholecystitis in the Laparoscopic Era
  publication-title: Aust. N. Z. J. Surg.
  doi: 10.1046/j.1440-1622.2000.01851.x
– volume: 14
  start-page: 78
  year: 2007
  ident: ref_26
  article-title: Diagnostic Criteria and Severity Assessment of Acute Cholecystitis: Tokyo Guidelines
  publication-title: J. Hepatobiliary Pancreat. Surg.
  doi: 10.1007/s00534-006-1159-4
– volume: 1142
  start-page: 221
  year: 2019
  ident: ref_10
  article-title: Human Chitinases: Structure, Function, and Inhibitor Discovery
  publication-title: Adv. Exp. Med. Biol.
  doi: 10.1007/978-981-13-7318-3_11
– volume: 52
  start-page: 313
  year: 2003
  ident: ref_19
  article-title: Potential Role of Immune System Activation-Associated Production of Neopterin Derivatives in Humans
  publication-title: Inflamm. Res.
  doi: 10.1007/s00011-003-1181-9
– ident: ref_17
– volume: 100
  start-page: 254
  year: 2015
  ident: ref_7
  article-title: Gangrenous Cholecystitis: Mortality and Risk Factors
  publication-title: Int. Surg.
  doi: 10.9738/INTSURG-D-13-00222.1
– volume: 14
  start-page: e32243
  year: 2022
  ident: ref_28
  article-title: The Accuracy of Neutrophil-to-Lymphocyte Ratio and Abdominal Computed Tomography to Predict the Severity of Acute Cholecystitis
  publication-title: Cureus
– volume: 20
  start-page: 751
  year: 2000
  ident: ref_4
  article-title: Gallbladder Stones: Imaging and Intervention
  publication-title: Radiographics
  doi: 10.1148/radiographics.20.3.g00ma16751
SSID ssj0000884217
Score 2.2564077
Snippet Gallstones are a common surgical pathology. Laparoscopic cholecystectomy represents the elective treatment. Complicated cases can increase the rate of...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1641
SubjectTerms Analysis
Appendicitis
Asymptomatic
Biochemistry
Biological markers
Biomarkers
Blood & organ donations
Cholecystectomy
Cholecystitis
Diagnosis
Enzymes
Evaluation
Gallbladder
Gallbladder diseases
Gallstones
Gangrene
Gastroenterology
Hepatology
Heterocyclic compounds
Histopathology
Hospitalization
Identification and classification
Inflammation
Interferon
Laparoscopy
Normal distribution
Pathology
Patients
Risk factors
Tumor necrosis factor-TNF
Ultrasonic imaging
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fS9xAEF9aC9IXsa2tsbZsQRCEYJLd_LknOQ9FCooPFe4t7F9M0ex5yT345ofoJ-wn6UxuL16k-LyTZMnM7Pxm97czhBxoxnTKtAwNZ1nICyNCyUYqTBSHcMqMjCxu6F9eZRc3_Oc0nfoNt8bTKldrYrdQa6dwj_w4yXOso5Kl_GT2EGLXKDxd9S003pJ3MUAVtOp8mvd7LOBBHCD38loeg-z--Le6j5MIQAiPB4Ho5XK8Fo-GXMm14HO-TbY8aqTjpZo_kDem_kg2L_25-CeymNyCZ7bzyoFxQVyiotb0yrgZVmKuqWjotWuRFwQvOa3cPXJy5g0FwEoBANKzvuQ3dZZOVixzo-mka5_7iISCqvn79GdMr6s711KkHz7ukJvzs1-Ti9A3VAgVz7M2tIrbHCGUABwSG0hmpLQmgVx0pGQsAQxyw1LNhS1EktmoAFUlIyNsqhMBUI19Jhu1q80uoVFhc11wpbTCAj1WgrSWGRPWMryNG5Cj1d8tla82jk0v7krIOlAV5ZoqAnLQC8-WRTb-L3aIairR9eBdSvgbBDAjLGJVjrszWcj4QHJ_IAkuo4bDK0WX3mWb8tnAAvKjH8YnkYZWG7dAmQIvnULmHZAvS7voJ8yyggEcTAOSDyymF8BC3sORurrtCnrDV-HL0d7r0_pK3mOve6SMx8U-2WjnC_MNEFErv3dm_w-hSg8Z
  priority: 102
  providerName: ProQuest
Title Chitotriosidase and Neopterin as Potential Biomarkers for the Evaluation of Complicated Cholecystitis—A Pilot Study
URI https://www.ncbi.nlm.nih.gov/pubmed/36836175
https://www.proquest.com/docview/2779499654
https://www.proquest.com/docview/2780062978
https://pubmed.ncbi.nlm.nih.gov/PMC9964990
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2077-0383
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000884217
  issn: 2077-0383
  databaseCode: KQ8
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 2077-0383
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000884217
  issn: 2077-0383
  databaseCode: ABDBF
  dateStart: 20160901
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 2077-0383
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000884217
  issn: 2077-0383
  databaseCode: DIK
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources (ISSN International Center)
  customDbUrl:
  eissn: 2077-0383
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000884217
  issn: 2077-0383
  databaseCode: M~E
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central (US National Library of Medicine)
  customDbUrl:
  eissn: 2077-0383
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000884217
  issn: 2077-0383
  databaseCode: RPM
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVPQU
  databaseName: Health & Medical Collection (ProQuest)
  customDbUrl:
  eissn: 2077-0383
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000884217
  issn: 2077-0383
  databaseCode: 7X7
  dateStart: 20190101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central Database Suite (ProQuest)
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 2077-0383
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000884217
  issn: 2077-0383
  databaseCode: BENPR
  dateStart: 20190101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 2077-0383
  dateEnd: 20250831
  omitProxy: true
  ssIdentifier: ssj0000884217
  issn: 2077-0383
  databaseCode: M48
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NattAEF7SBEIupf9Vm5otBAoFtbJ2Ja0PpTjGIRRsTKnBN7G_RMGRUluG-JaH6BP2STojS8IKOfW8s9pFM6v5RjvzDSFnhjETMaN8y1nsc2Glr9hA-6Hm4E6ZVYHDH_qTaXw55z8W0eKANM046xe4fjS0w35S89Xyy93v7Xc48N8w4oSQ_eu1vumHASALLGA_ApcUonlPapxffZKF4IC9d_V5D-eckGMWCwauPOo4p4ef6D0f1c2f3HNIF8_I0xpJ0uFO9c_Jgc1fkONJfVf-kmxGV3Bay1VWgMGBr6IyN3Rqi1tkZ86pXNNZUWKuEDzkPCtuME9ntaYAYimAQjpuacBp4eioyTy3ho6qlrpbTDLI1n_v_wzpLFsWJcWUxO0rMr8Y_xpd-nWTBV_zJC59p7lLEFZJwCZ9CwGOUs6GEJ8OtOorAIjcsshw6YQMYxcIUF84sNJFJpQA39hrcpgXuX1LaCBcYgTX2mgk7XEKpI2KmXSOYYWuRz43bzfVNQM5NsJYphCJoFbSPa145KwVvt0Rbzwu9gnVlKKBwLO0rKsKYEdIbJUOq3taiAJB8rQjCcdId4cbRaeNFaZhkiB5Txxxj3xsh3EmpqblttigjMBCVIjGPfJmZxfthhu78kjSsZhWAMm9uyN5dlWRfMOqsHLw7r9nvicnIQAyzDDvi1NyWK429gMAqFL1yJNkkfTI0fl4OvvZq47KP8rpIQM
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9NAFB5VRQIuiB3TAoNUhIRk1Z4ZLzkgFEKrlDZRD62UmxnPohq1dpo4QrnxI_gd_Ch-Ce95I0aIW8_zbI_8tu_NvIWQPc25DrhOXSN46IrYSDflA-UyJcCdcpN6Fg_0J9NwfC4-z4LZFvnZ1sJgWmVrEytDrQuFZ-T7LIqwj0oYiA_zaxenRuHtajtCoxaLY7P-BiHb8v3RJ-DvG8YOD85GY7eZKuAqEYWla5WwEeIICc7YN4Do09QaBgHZQKV-CohIGB5oIW0sWWi9GPbLBkbaQDMZV1MiwOTfEtwT2Ks_mkXdmQ5orACIX5cBcj7w9r-qK595AHqE33N8f5v_Df_Xz83ccHaH98m9BqXSYS1WD8iWyR-S25PmHv4RWY0uwBKUi6wAYQY_SGWu6dQUc-z8nFO5pKdFiXlI8JKPWXGFOUCLJQWATAFw0oOuxTgtLB21We1G01E1rneNCQzZ8tf3H0N6ml0WJcV0x_Vjcn4jv_oJ2c6L3Dwj1IttpGOhlFbYEMimQK3TkEtrOVb_OuRd-3cT1XQ3xyEblwlEOciKZIMVDtnriOd1U49_k71FNiWo6vAuJZuKBdgRNs1KhtUdMESYQLnbowQVVf3lltFJYyKWyR-BdsjrbhmfxLS33BQrpImxyBUifYc8reWi2zAPYw7wM3BI1JOYjgAbh_dX8uyiaiAOX4Uve8__v61X5M74bHKSnBxNj3fIXQboDtPV_XiXbJeLlXkBaKxMX1YqQMmXm9a53yoyTBE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF5VRaq4IN4YCixSERKSFXt3_cgBoZA2aimNcqBSbsb7UlO1dogdodz4Efwafg6_hBm_iBHi1vOO7ZV3Ht_sfjtDyIHmXAdcS9cIHroiNqkr-VC5TAkIp9xIz-KG_tk0PD4XH-fBfIf8bO_CIK2y9YmVo9a5wj3yAYsirKMSBmJgG1rE7HDyfvnVxQ5SeNLattOoVeTUbL5B-la8OzmEtX7N2OTo8_jYbToMuEpEYelaJWyEmCKFwOwbQPdSWsMgORsq6UtAR8LwQIvUxikLrRfD3NnQpDbQLI2rjhHg_m9FXHCkk0XzqNvfAesVAPfrK4GcD73Bpbr2mQcASPi9IPh3KNiKhX2e5lbgm9wldxrESke1it0jOya7T_bOmjP5B2Q9vgCvUK4WOSg2xESaZppOTb7EKtAZTQs6y0vkJMFLPizya-QDrQoKYJkC-KRHXblxmls6bhnuRtNx1bp3g2SGRfHr-48RnS2u8pIi9XHzkJzfyK9-RHazPDNPCPViG-lYKKUVFgeyEqS1DHlqLcebwA552_7dRDWVzrHhxlUCGQ8uRbK1FA456ISXdYGPf4u9wWVK0OzhXSptbi_AjLCAVjKqzoMh2wTJ_Z4kmKvqD7cLnTTuokj-KLdDXnXD-CRS4DKTr1EmxguvkPU75HGtF92EeRhzgKKBQ6KexnQCWES8P5ItLqpi4vBV-LL39P_Tekn2wNqSTyfT02fkNgOgh8x1P94nu-VqbZ4DMCvli8oCKPly0yb3G2lyUEw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chitotriosidase+and+Neopterin+as+Potential+Biomarkers+for+the+Evaluation+of+Complicated+Cholecystitis%E2%80%94A+Pilot+Study&rft.jtitle=Journal+of+clinical+medicine&rft.au=Nechita%2C+Vlad-Ionu%C5%A3&rft.au=Hajjar%2C+Nadim+Al&rft.au=Drugan%2C+Cristina&rft.au=C%C4%83tan%C4%83%2C+Cristina-Sorina&rft.date=2023-02-18&rft.pub=MDPI&rft.eissn=2077-0383&rft.volume=12&rft.issue=4&rft_id=info:doi/10.3390%2Fjcm12041641&rft_id=info%3Apmid%2F36836175&rft.externalDocID=PMC9964990
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2077-0383&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2077-0383&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2077-0383&client=summon